Non-Current Liabilities
Total Liabilities
ResMed Total Liabilities increased by 5.0% to $2.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.4%, from $2.02B to $2.29B. Over 4 years (FY 2021 to FY 2025), Total Liabilities shows an upward trend with a 4.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
Detailed definition
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Peer comparison
Used across all industries to assess the overall debt burden relative to equity and assets.
Metric ID:
total_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.84B | $1.70B | $1.59B | $1.63B | $1.74B | $1.74B | $2.94B | $2.78B | $2.62B | $2.49B | $2.42B | $2.18B | $2.01B | $2.03B | $1.89B | $2.02B | $2.21B | $2.19B | $2.18B | $2.29B |
| QoQ Change | — | -7.6% | -6.7% | +2.4% | +6.7% | +0.6% | +68.4% | -5.3% | -5.7% | -5.0% | -2.7% | -9.8% | -8.1% | +0.9% | -6.9% | +7.0% | +9.2% | -0.9% | -0.2% | +5.0% |
| YoY Change | — | — | — | — | -5.8% | +2.4% | +84.9% | +71.0% | +51.1% | +42.7% | -17.5% | -21.5% | -23.4% | -18.6% | -22.1% | -7.5% | +9.9% | +7.9% | +15.6% | +13.4% |
Range$1.59B – $2.94B
CAGR+4.7%
Avg YoY Growth+11.4%
Median YoY Growth+5.2%
Total Liabilities at Other Companies
Frequently Asked Questions
- What is ResMed's total liabilities?
- ResMed (RMD) reported total liabilities of $2.29B in Q1 2026.
- How has ResMed's total liabilities changed year-over-year?
- ResMed's total liabilities increased by 13.4% year-over-year, from $2.02B to $2.29B.
- What is the long-term trend for ResMed's total liabilities?
- Over 4 years (2021 to 2025), ResMed's total liabilities has grown at a 4.6% compound annual growth rate (CAGR), from $1.84B to $2.21B.
- What does total liabilities mean?
- The total amount of money the company owes to all creditors and stakeholders.